|
Volumn 18, Issue 3-4, 2012, Pages 262-276
|
Effects of bone morphogenetic proteins on primary human renal cells and the generation of bone morphogenetic protein-7-expressing cells for application in bioartificial kidneys
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BONE;
PEPTIDES;
PURIFICATION;
BIOARTIFICIAL;
BONE MORPHOGENETIC PROTEINS;
CELL PERFORMANCE;
CLINICAL TRIAL;
CONCENTRATION-DEPENDENT;
FUNCTIONAL PERFORMANCE;
GROWTH FACTOR;
IN-VITRO;
OPTIMAL CONCENTRATION;
RENAL CELL;
SUBSTRATE SURFACE;
THERAPEUTIC APPLICATION;
TRANSDIFFERENTIATION;
CELLS;
ACTIN;
ALKALINE PHOSPHATASE;
BONE MORPHOGENETIC PROTEIN 2;
GAMMA GLUTAMYLTRANSFERASE;
OSTEOGENIC PROTEIN 1;
RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2;
RECOMBINANT PROTEIN;
SMAD PROTEIN;
TRANSFORMING GROWTH FACTOR BETA;
ANIMAL;
ANTIBODY SPECIFICITY;
ARTICLE;
ARTIFICIAL KIDNEY;
BIOREACTOR;
BONE DEVELOPMENT;
CELL CULTURE;
CYTOLOGY;
DRUG EFFECT;
ENZYMOLOGY;
EPITHELIUM;
GENE EXPRESSION REGULATION;
GENETIC ENGINEERING;
GENETICS;
HUMAN;
KIDNEY PROXIMAL TUBULE;
METABOLISM;
METHODOLOGY;
MOUSE;
PHOSPHORYLATION;
SECRETION;
TISSUE ENGINEERING;
ACTINS;
ALKALINE PHOSPHATASE;
ANIMALS;
BIOREACTORS;
BONE MORPHOGENETIC PROTEIN 2;
BONE MORPHOGENETIC PROTEIN 7;
CELLS, CULTURED;
EPITHELIUM;
GAMMA-GLUTAMYLTRANSFERASE;
GENE EXPRESSION REGULATION;
GENETIC ENGINEERING;
HUMANS;
KIDNEY TUBULES, PROXIMAL;
KIDNEY, ARTIFICIAL;
MICE;
ORGAN SPECIFICITY;
OSTEOGENESIS;
PHOSPHORYLATION;
RECOMBINANT PROTEINS;
SMAD PROTEINS;
TISSUE ENGINEERING;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 84856279685
PISSN: 19373341
EISSN: 1937335X
Source Type: Journal
DOI: 10.1089/ten.tea.2011.0149 Document Type: Article |
Times cited : (4)
|
References (4)
|